These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25619932)

  • 1. Small molecule inhibitors of Clostridium difficile toxin B-induced cellular damage.
    Tam J; Beilhartz GL; Auger A; Gupta P; Therien AG; Melnyk RA
    Chem Biol; 2015 Feb; 22(2):175-85. PubMed ID: 25619932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and entry of Clostridium difficile toxin B is mediated by multiple domains.
    Manse JS; Baldwin MR
    FEBS Lett; 2015 Dec; 589(24 Pt B):3945-51. PubMed ID: 26602083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR studies of novel benzodiazepinedione-based inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB).
    Letourneau JJ; Stroke IL; Hilbert DW; Cole AG; Sturzenbecker LJ; Marinelli BA; Quintero JG; Sabalski J; Li Y; Ma L; Pechik I; Stein PD; Webb ML
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3601-3605. PubMed ID: 30392779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.
    Huelsenbeck J; Dreger S; Gerhard R; Barth H; Just I; Genth H
    Infect Immun; 2007 Feb; 75(2):801-9. PubMed ID: 17145947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-Molecule Allosteric Triggers of Clostridium difficile Toxin B Auto-proteolysis as a Therapeutic Strategy.
    Ivarsson ME; Durantie E; Huberli C; Huwiler S; Hegde C; Friedman J; Altamura F; Lu J; Verdu EF; Bercik P; Logan SM; Chen W; Leroux JC; Castagner B
    Cell Chem Biol; 2019 Jan; 26(1):17-26.e13. PubMed ID: 30482680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
    Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
    Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of Clostridium difficile toxins to human milk oligosaccharides.
    El-Hawiet A; Kitova EN; Kitov PI; Eugenio L; Ng KK; Mulvey GL; Dingle TC; Szpacenko A; Armstrong GD; Klassen JS
    Glycobiology; 2011 Sep; 21(9):1217-27. PubMed ID: 21610194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B.
    Yuan P; Zhang H; Cai C; Zhu S; Zhou Y; Yang X; He R; Li C; Guo S; Li S; Huang T; Perez-Cordon G; Feng H; Wei W
    Cell Res; 2015 Feb; 25(2):157-68. PubMed ID: 25547119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.
    Li S; Shi L; Yang Z; Zhang Y; Perez-Cordon G; Huang T; Ramsey J; Oezguen N; Savidge TC; Feng H
    Infect Immun; 2015 Feb; 83(2):502-13. PubMed ID: 25404023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface proteins from Lactobacillus kefir antagonize in vitro cytotoxic effect of Clostridium difficile toxins.
    Carasi P; Trejo FM; Pérez PF; De Antoni GL; Serradell Mde L
    Anaerobe; 2012 Feb; 18(1):135-42. PubMed ID: 22126976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kefir-isolated Lactococcus lactis subsp. lactis inhibits the cytotoxic effect of Clostridium difficile in vitro.
    Bolla PA; Carasi P; Serradell Mde L; De Antoni GL
    J Dairy Res; 2013 Feb; 80(1):96-102. PubMed ID: 23217732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene.
    Olling A; Seehase S; Minton NP; Tatge H; Schröter S; Kohlscheen S; Pich A; Just I; Gerhard R
    Microb Pathog; 2012 Jan; 52(1):92-100. PubMed ID: 22107906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Fanning S; Kyne L
    Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
    Genth H; Dreger SC; Huelsenbeck J; Just I
    Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile toxins: mechanism of action and role in disease.
    Voth DE; Ballard JD
    Clin Microbiol Rev; 2005 Apr; 18(2):247-63. PubMed ID: 15831824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophilin-facilitated membrane translocation as pharmacological target to prevent intoxication of mammalian cells by binary clostridial actin ADP-ribosylated toxins.
    Ernst K; Langer S; Kaiser E; Osseforth C; Michaelis J; Popoff MR; Schwan C; Aktories K; Kahlert V; Malesevic M; Schiene-Fischer C; Barth H
    J Mol Biol; 2015 Mar; 427(6 Pt A):1224-38. PubMed ID: 25058685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
    Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
    PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
    Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
    Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.
    Antunes A; Dupuy B
    Methods Mol Biol; 2010; 646():93-115. PubMed ID: 20597005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of the cytopathic effect induced by Clostridium difficile Toxin B by active Rac1.
    Halabi-Cabezon I; Huelsenbeck J; May M; Ladwein M; Rottner K; Just I; Genth H
    FEBS Lett; 2008 Nov; 582(27):3751-6. PubMed ID: 18848548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.